These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 1691734

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Neurotoxicity associated with adenine arabinoside monophosphate in the treatment of chronic hepatitis B virus infection.
    Lok AS, Wilson LA, Thomas HC.
    J Antimicrob Chemother; 1984 Jul; 14(1):93-9. PubMed ID: 6207158
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prolonged inhibition of hepatitis B virus replication with vidarabine monophosphate in chronic active type B hepatitis.
    Guardia J, Esteban R, Buti M, Jardí R, Allende H, Esteban JI.
    Liver; 1986 Apr; 6(2):118-22. PubMed ID: 2426552
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Adenine arabinoside 5'-monophosphate in patients with chronic hepatitis B: comparison of the efficacy in patients with high and low viral replication.
    Marcellin P, Pouteau M, Loriot MA, Boyer N, Degos F, Calès P, Bettan L, Bacq Y, Coppére H, Grange JD.
    Gut; 1995 Mar; 36(3):422-6. PubMed ID: 7535285
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Differential effect of ARA-AMP on serum DNA polymerase activity and serum HBV-DNA in chronic hepatitis B virus infection. A possible reason for lack of efficacy.
    Alexander GJ, Fagan EA, Rolando N, Guarner P, Callender ME, Eddleston AL, Williams R.
    J Hepatol; 1986 Mar; 3 Suppl 2():S81-6. PubMed ID: 2439580
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of liver disease on pharmacokinetics and toxicity of 9-beta-D-arabinofuranosyladenine-5-phosphate.
    Preiksaitis JK, Lank B, Ng PK, Brox L, LePage GA, Tyrrell DL.
    J Infect Dis; 1981 Oct; 144(4):358-64. PubMed ID: 6169773
    [Abstract] [Full Text] [Related]

  • 17. [Long-term results of treatment of chronic active hepatitis B with vidarabine monophosphate].
    Causse X, Guérou V, Rougier P, Trépo C.
    Gastroenterol Clin Biol; 1993 Oct; 17(2):144-5. PubMed ID: 7684714
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.